Case Study: Teva Pharmaceuticals
Company: Teva Pharmaceuticals
Customer Overview
Teva Pharmaceuticals is a global leader in generic and specialty medicines. VROC initium helps the R&D site, where the team focuses on formulating stable, efficacious drug products across various dosage forms.
Key Challenges Addressed
- Viscosity Optimization: Required precise control over viscosity for injectable and topical formulations to ensure bioavailability, ease of administration, and manufacturability.
- Sample Volume Constraints: Faced limitations in early-phase formulation work where sample availability was minimal.
- Automation & Efficiency: Sought ways to reduce manual effort in testing and improve throughput without compromising data quality.
Solutions Implemented
- Instrument: VROC initium one
- Application: Used to measure shear-dependent viscosity profiles of various formulations and injectables. Allowed for small-sample, high-accuracy testing.
- Integration: Adopted into Teva’s formulation workflows for buffer, concentration and excipient screening.
Customer Success Highlights
- Small sample volumes: For early stage formulation and lack of sample volume available overall.
- Faster Development Cycles: Enabled more rapid decision-making during excipient selection and prototype evaluation.
- Team Adoption: Tool is now a go-to for formulation screening across multiple projects.
COMMENTS